Centre for Inflammation Research

Science Summaries – 2018

Science summaries from 2018

Bacterial imaging probe is safe for patient use, study finds

Images of lung tissue of a patient with bronchiectasis
October 2018: Imaging technology that detects deadly pneumonia infections in under 60 seconds is safe and practical for clinical use, a study has found.

Imaging advance set to speed up quest for cell-based therapies

August 2018: Cancer treatments that involve transplanting cells into patients could move forward faster thanks to a new imaging system. 

Lung study points to therapies for chronic coughing disease

A cartoon showing airways with and without bronchiectasis
June 2018: Fresh insights into a potentially life-threatening lung disease that causes persistent coughing could pave the way for new therapies

Scientists replicate cause and symptoms of human womb condition

Woman's stomach showing where pain is felt - iStock-537335764 Vonschonertagen
June 2018: CIR researchers have used mice to study endometriosis – a condition that can affect the womb of human females.

Bowel disease study points to new therapies for lifelong conditions

A 3D graphic of a human highlighting where the bowel is.
May 2018: Treatments for incurable bowel conditions may be a step closer following the discovery of a key molecule associated with disease flare-ups.

Fertility study finds hormone that could support early pregnancy

A photo of a pregnant woman
February 2018: Scientists have identified a hormone that could help prepare the womb lining for pregnancy.

Lung disease patients show defective white blood cells

Micrograph of macrophages
February 2018: A defect has been detected that affects how white blood cells eat bad bacteria in the lungs

New insight into how the body ‘gobbles up’ asthma-inducing cells

Human lungs ©iStock.com/yodiyim
February 2018: CIR researchers look into potential novel therapy for treating allergy-induced lung diseases.

£1.7M awarded to help fight chronic liver disease

January 2018: A clinical study has been given a major financial boost to tackle a silent killer that could affect one in four Scots.